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Abstract
 
Absence of CD4 impairs the efficiency of T cell receptor (TCR) signaling in response to ma-
jor histocompatibility complex (MHC) class II–presented peptides. Here we use mice carry-
 
ing a conditional 
 
Cd4
 
 allele to study the consequences of impaired TCR signaling after the
completion of thymocyte development. We show that loss of CD4 decreases the steady-state
proliferation of T cells as monitored by in vivo labeling with bromo-deoxyuridine. More-
over, T cells lacking CD4 compete poorly with CD4-expressing T cells during proliferative
expansion after transfer into lymphopenic recipients. The data suggest that T cells compete
with one another during homeostatic proliferation, and indicate that the basis of this compe-
tition is TCR signaling.
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Introduction
 
Ligand-dependent signaling by TCRs determines multiple
aspects of T cell development and differentiation. In the
absence of encounter with peptide–MHC ligands, T cells
become apoptotic in the thymus and do not undergo clonal
expansion during immune responses in the periphery.
They also demonstrate survival defects and proliferative
problems when placed into MHC-deficient environments,
suggesting that peptide–MHC engagement is a necessary
component of general T cell homeostasis (1–5).
Whereas the significance of TCR signaling in the thy-
mus and during immune responses is clear, the nature of its
role in T cell homeostasis and postthymic selection of naive
T cells is unresolved. It is unclear, for instance, whether
TCR signaling in response to endogenous peptide–MHC
ligands constitutes a potent or minor selection for naive T
cells. Moreover, it remains to be determined whether se-
lection of this sort confers any obvious benefit on the im-
mune system in terms of its ability to mount pathogen-spe-
cific responses and/or to avoid autoimmune responses.
The CD4 coreceptor is an important part of the TCR
signaling machinery used by helper lineage T cells (6–8). Its
presence during antigen recognition enhances the recogni-
tion of low affinity ligands by TCRs and reduces the
threshold concentration required for T cell activation by
high affinity ligands (9–11). Nonetheless, CD4 can be dis-
pensable for T cell development in the thymus and activa-
tion in the periphery (12–14), reflecting the modest nature
of its contribution to TCR signaling. An induced CD4 de-
ficiency is therefore one means for selectively impairing the
efficiency of the TCR signal without completely eliminat-
ing it (9).
In this paper, we have used conditional gene inactivation
systems to study the consequences of impairing the TCR
signal after the completion of thymic-positive selection.
The data provide evidence of competition between T cells
based on the strength of the TCR signal they receive and
are consistent with the existence of extra-thymic MHC–
peptide-dependent T cell selection.
 
Materials and Methods
 
Gene Targeting and Generation of Mutant Mice.
 
To generate
the 
 
Cd4
 
 targeting construct, a 2.2-Kb 
 
Bgl
 
 II fragment containing
exons 2 and 3 of the 
 
Cd4
 
 gene was cloned into a modified form
of pBluescript-KS
 
 
 
. A double-stranded oligonucleotide linker
containing a 
 
loxP
 
 and a 
 
Bam
 
H I site was then inserted into a 
 
Sac
 
 I
site upstream of the initiator methionine in exon 2. A down-
stream 6.5-Kb 
 
Bgl
 
 II-
 
Asp
 
718 I fragment containing exons 4 and 5
of the 
 
Cd4
 
 gene was added to the construct, followed by the
blunt-ended insertion of a human 
 
CD52
 
 cDNA fused to a 
 
loxP
 
-
flanked 
 
MC1-neo
 
 gene (gift of Hua Gu, National Institutes of
Health, Bethseda, MD) into the 
 
Bgl
 
 II site in the third intron.
The construct was linearized and electroporated into JM-1 ES
cells (129/SvJ) (15). ES cell colonies were screened using a probe
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from the first intron of the 
 
Cd4
 
 gene hybridized to Southern
blots of 
 
Sac
 
 I–digested genomic DNA according to standard pro-
cedures (16). Cells carrying the desired mutation were transiently
transfected with a Cre expression vector and replated at low den-
sity on irradiated primary embryonic fibroblasts. Colonies that
had lost the 
 
loxP
 
-flanked 
 
MC1-neo
 
 gene by Cre recombination
were identified by Southern blot analysis (as above), and cells
from them were subsequently microinjected into C57BL/6 blas-
tocysts. Chimeric male mice were crossed to C57BL/6 females to
establish lines of mice carrying the 
 
Cd4
 
 mutation.
The generation of 
 
dLck-hcre
 
 transgenic mice expressing a
codon optimized form of the 
 
cre
 
 open reading frame under the
control of the distal 
 
Lck
 
 promoter (17) will be described else-
where (unpublished data). These mice were bred to animals car-
rying the conditional CD4 allele and then backcrossed to 
 
Cd4
 
 
 
/
 
 
 
mice to generate 
 
Cd4
 
lox/
 
 
 
 
 
dLck-hcre
 
 mice. All mice were housed
in the Parnassus Heights pathogen-free barrier facility at the Uni-
versity of California at San Francisco.
 
Antibodies and Flow Cytometry.
 
FITC-, PE-, or TC-conju-
gated antibodies and Annexin V were purchased from Caltag or
BD PharMingen. 0.3 
 
 
 
 10
 
6
 
 lymphocytes or thymocytes were in-
cubated for 30 min on ice in a volume of 25 
 
 
 
l of FACS
 
®
 
 buffer
(PBS with 0.3% BSA and 0.01% NaN
 
3
 
) containing antibodies at
saturating concentrations. The cells were washed twice in FACS
 
®
 
buffer, stained with secondary reagents as necessary, washed
again, and then analyzed using a FACScan™ flow cytometer
(Becton Dickinson) and CELLQuest™ or Flowjo software. An-
nexin V staining was performed following the manufacturer’s
protocol (BD PharMingen).
 
BrdU Labeling and Detection.
 
8-wk-old mice were provided
bromo-deoxyuridine (BrdUrd)
 
*
 
 (0.8 mg/ml) in their drinking
water for a period of 20 d. On days 5, 10, 15, and 20, mesenteric
and inguinal lymph nodes were harvested from selected mice and
stained for BrdUrd incorporation using a modification of pub-
lished methods (18). Briefly, 10
 
6
 
 cells were stained in FACS
 
®
 
buffer with antibodies, washed twice, and then resuspended in 40
 
 
 
l of ice-cold 0.15 M NaCl. While mixing gently, 96 
 
 
 
l of ice-
cold 95% ethanol were added drop-wise to the cells; they were
then incubated on ice in the dark for 30 min before washing with
160 
 
 
 
l of cold PBS. The cells were fixed for 30 min at room
temperature by adding 150 
 
 
 
l of PBS containing 1% paraformal-
dehyde and 0.03% Tween-20. After this step, the cells were spun
down and incubated with 15,000 U of DNase I (Sigma-Aldrich)
in 100 
 
 
 
l of 4.2 mM MgCl
 
2
 
, 0.15 M NaCl, pH 5.0, for 10 min at
room temperature. After washing with 200 
 
 
 
l of PBS, the cells
were incubated in the dark at room temperature for 30 min with
50 
 
 
 
l of a 1:5 dilution of FITC-anti-BrdUrd (BD PharMingen).
Finally, the cells were washed twice with PBS, resuspended in
FACS
 
®
 
 buffer and analyzed using the FACScan™. Electronic
gating was used to quantify cells that stained brightly with FITC
anti-BrdUrd and were therefore likely to have undergone post-
thymic proliferation (49).
 
In Vivo Depletion of CD4
 
 
 
 T Cells, KLH Immunization, and In
Vitro Antigen Restimulation Assays.
 
Mice were injected with 0.5
mg of purified anti-CD4 mAb (GK1.5) intraperitoneally on 3 d
consecutively. A fourth intraperitoneal injection of 1 mg of anti-
body was given on day 6 before immunization on day 7. CD4-
depleted or control mice were immunized intraperitoneally with
100 
 
 
 
g of KLH in Alum (Pierce Chemical Co.), and their spleens
 
were harvested 7 d after immunization. 10
 
6
 
 CD8-depleted sple-
nocytes (containing equivalent numbers of CD4 lineage cells)
were stimulated in vitro with 50 
 
 
 
g/ml KLH in 96-well flat-bot-
tomed plates. Supernatants were removed from the stimulated
cultures 48 h after initiation, and these were assayed for cytokine
content by ELISA using antibodies and standards purchased from
BD PharMingen.
 
Cell Transfers and CFSE Labeling.
 
Bone marrow preparations
harvested from 
 
Cd4
 
lox/
 
 
 
 
 
dlck-hcre
 
3778
 
 and 
 
dlck-hcre
 
3779
 
 mice were
depleted of T cells using anti-Thy1.2 MACS
 
®
 
 beads and Miltenyi
LS
 
 
 
 columns. 5 
 
 
 
 10
 
6
 
 T cell–depleted bone marrow cells were
injected into the tail veins of irradiated (1,100 rads) 6-wk-old
C57BL/6 female mice. The recipients received water containing
neomycin (1.1%; Sigma-Aldrich) and polymixin B sulfate (850
U/ml; Paddock Laboratories) for 6–8 wk.
Single cell suspensions of pooled lymph nodes and spleen were
prepared from C57BL/6, 
 
Cd4
 
 
 
/
 
 
 
, and 
 
dlck-hcre
 
 
 
Cd4
 
lox/
 
 
 
 bone
marrow chimeras. CD4
 
 
 
 T cells were removed from selected
samples using anti-CD4 MACS
 
®
 
 beads and LS
 
 
 
 columns. The
cells were washed in PBS and incubated in 2.5 
 
 
 
M CFSE in PBS
for 8 min at room temperature. FCS was added to quench the
CFSE and the cells were washed twice in IMDM/10%FCS me-
dium. 3 
 
 
 
 10
 
7
 
 labeled cells were injected into the tail veins of re-
combination activating gene (RAG)-1
 
 
 
/
 
 
 
 mice.
 
Results
 
Generation and Analysis of Mouse Lines that Allow for Stage-
specific Inactivation of the CD4 Gene.
 
A conditional allele
of the mouse 
 
Cd4
 
 gene was created in ES cells by targeted
mutagenesis. The targeting construct used for this purpose
featured 
 
loxP
 
 sites both upstream of the initiator methio-
nine in exon 2 and also downstream of exon 3 within the
third intron (Fig. 1 A). Cre-mediated recombination be-
tween these two 
 
loxP
 
 sites deletes a critical part of the gene
which encodes both the CD4 signal peptide and a part of
the molecule that is necessary for MHC class II binding
(19). ES cells carrying the desired mutation were identified
by standard procedures (Fig. 1 B) and were subsequently
transiently transfected with a Cre recombinase expression
vector to delete the linked 
 
loxP
 
-flanked 
 
MC1-neo
 
 gene.
The conditional 
 
Cd4
 
 allele (hereafter referred to as 
 
Cd4
 
lox
 
)
was established in the germline of mice by blastocyst mi-
croinjection of the mutant ES cells.
To inactivate the 
 
Cd4
 
 gene at different stages in T cell
development, we used three recently developed lines of
mice that express the Cre recombinase under the control
of the distal promoter of the 
 
Lck
 
 gene. The developmen-
tal onset of Cre recombination in these mice is variable
and has been studied using a Cre-dependent reporter line
and other approaches (unpublished data). Cre recombina-
tion in line 3785 is highly penetrant in T cells, with its
onset being largely after the preTCR signal has been de-
livered. In contrast, Cre recombination occurs later in
lines 3778 and 3779, primarily after cells have rearranged
the locus encoding TCR-
 
 
 
 and progressed through the
TCR-
 
  
 
 checkpoint to the TCR
 
hi
 
 stage of development.
Cre recombination in T cells of line 3778 is less efficient
than in 3779, which itself shows less recombination than
3785.
 
*
 
Abbreviations used in this paper:
 
 BrdUrd, bromo-deoxyuridine; LACK,
 
Leishmania major
 
 homologue of mammalian RACK1; RAG, recombina-
tion activating gene. 
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Cre transgenic mice were generated that had both a null
and conditional allele of 
 
Cd4
 
 (i.e., 
 
Cd4
 
lox/
 
  
 
dLck-hcre
 
 mice)
so that recombination on only one chromosome would be
required to cause loss of CD4. Thymocytes and T cells
from the mice were then analyzed by flow cytometry as
shown in Fig. 2. Inactivation of the 
 
Cd4
 
 gene in line 3785
occurred early during thymocyte development so that
roughly half of the TCR
 
lo
 
 small cells failed to express CD4.
These mice were similar to 
 
Cd4
 
 
 
/
 
 
 
 mice in the overabun-
dance of CD8
 
 
 
 T cells found in their lymph nodes, and
their paucity of peripheral CD4 lineage T cells (identifiable
by expression of the 
 
  
 
 TCR and absence of expression of
CD8). Such a phenotype indicates that most double-posi-
tive stage thymocytes in the mice had inactivated the 
 
Cd4
 
gene before undergoing positive selection where the func-
tion of CD4 first becomes significant. This interpretation
was substantiated by analysis of cells that had upregulated
the TCR (Fig. 2) or CD69 (data not shown), most of
which expressed very little or no CD4 in line 3785. The
similar representation of CD4 lineage cells in 
 
Cd4
 
lox/
 
 
 
dLck-hcre
 
3785
 
 and 
 
Cd4
 
 
 
/
 
 
 
 mice also confirmed that the
 
Cd4
 
lox
 
 allele performed as expected, causing loss of CD4
expression and function after Cre recombination.
Lines 3778 and 3779 showed near normal distributions
of CD4 expression at the TCR
 
lo
 
 stage of development,
with loss of CD4 becoming prevalent primarily at the more
mature TCR
 
hi stage. Cd4lox/   dLck-hcre3778 and Cd4lox/ 
dLck-hcre3779 mice had substantial numbers of mature CD4
lineage cells in their lymph nodes (85   10 [n   15] and
73   12 [n   18] percent of the nontransgenic controls,
respectively). This was true even though 29   3% and
81   4% of the CD4 lineage cells lacked CD4 expression
in these mice. Steady-state analysis of this sort indicated
that in contrast to mice showing early loss of CD4 (Cd4lox/ 
dLck-hcre3785 or Cd4 /  mice), CD4-deficient cells could
accumulate in substantial numbers when CD4 loss oc-
curred late in development.
Immune Responses Mediated by CD4-deficient T Cells.
We have found previously that Th cells in Cd4 /  mice
use TCRs that have similar ligand-binding properties to
those in CD4-expressing mice (9) consistent with a modest
role for CD4 in regulating the selection of the TCR reper-
toire. Nevertheless, it was of interest to examine the anti-
gen-responsiveness of CD4 lineage cells that had lost CD4
as a late-thymic or postthymic event, as in Cd4lox/  dLck-
hcre3778 mice. Most, if not all of the CD4-deficient T
helper cells in these mice would have undergone thymic-
positive selection in the presence of CD4, allowing for a
direct assessment of how postthymic loss of CD4 might
impair antigen responsiveness.
In one series of experiments, we immunized cohorts of
mice with KLH and then used an in vitro restimulation as-
say to monitor the outcome of in vivo clonal expansion.
The Cd4lox/  dLck-hcre3778 mice were pretreated with cyto-
toxic anti-CD4 mAb, to deplete CD4-expressing cells and
thus ensure that the responsive T cells lacked CD4
throughout the immunization procedure. As shown in Fig.
3 A, the CD4-deficient T cells were capable of vigorous
responses to this antigen. Interestingly, as observed previ-
ously for Cd4 /  Th cells (20–22) the late loss of CD4 sig-
nificantly compromised TH2-mediated IL-4 secretion, but
did not impair TH1 responses (Fig. 3 A). Thus, these data
reveal the capacity of the CD4-deficient T cells to prolifer-
ate in vivo in response to antigenic stimulation, while also
providing further support for the importance of CD4 in
TH2 differentiation.
In related experiments, we immunized Cd4lox/   dLck-
hcre3778 and Cd4lox/  dLck-hcre3779 mice with the Leishmania
major homologue of mammalian RACK1 (LACK) antigen
(23, 24). To increase the precursor frequency of antigen-
reactive cells in the mice we used animals expressing a
transgene-derived LACK-reactive TCR-  chain (9), and
detected cells carrying LACK-reactive TCR heterodimers
using a fluorescent MHC–peptide multimer (25). These
TCR-  transgenic mice have a diverse TCR repertoire
because of the rearrangement of endogenous TCR-  chain
genes, but they mount vigorous responses to LACK that
are characterized by the rapid accumulation of large num-
Figure 1. Gene targeting to create a conditional Cd4 allele. (A) Design
of the targeting construct used to insert loxP sites into the Cd4 gene and
structure of the mutant Cd4 allele before and after Cre recombination.
The location of the intron 1 probe used on Southern blot analyses is indi-
cated, as are the sizes of the diagnostic Sac I fragments it detects. Enzyme
sites are labeled as follows: BamH I – B; Bgl II – G; Hind III – H; Sac I –
S; Kpn I – K; and loxP – L. (B) Southern blot analysis of Sac I–digested tail
DNA from mice of the indicated genotypes probed with the intron 1
probe. (C) Southern blot analysis of Sac I–digested tail, thymus, and
lymph node DNA from dLCk-hcre transgenic Cd4lox/  mice hybridized
with the intron 1 probe. The sizes of the wild-type and recombined or
unrecombined Cd4lox bands are indicated.1724 Conditional Inactivation of the Cd4 Gene
bers of LACK-reactive T cells in the draining lymph nodes
(9). In both Cd4lox/  dLck-hcre3778 and Cd4lox/  dLck-hcre3779
mice, LACK-reactive cells were equivalently represented
in both the CD4-expressing and CD4-deficient popula-
tions of T helper cells by flow cytometry (Fig. 3 B and C).
These results again indicate that despite the expected defi-
ciency in TCR function, cells that lack CD4 retain the ca-
pacity to recognize and mount effective proliferative re-
sponses to antigens.
Differences in Th Cell Turnover Dependent on the Timing of
CD4 Loss. Increased apoptosis of CD4 lineage cells has
been observed previously in Cd4 /  mice (26) and in mice
with an MHC class II mutation that blocks CD4 binding
(27). In Cd4 /  mice, this apoptosis is partially counter-
acted by a marked increase in homeostatic T helper cell
proliferation, with the net result of both effects being a re-
duced but nonetheless stable complement of CD4 lineage
cells (26). To test whether late loss of CD4 (in lines 3778
and 3779) was also associated with increased apoptosis and
homeostatic proliferation of CD4 CD8  T cells, the
Cd4lox/  dLck-hcre transgenic mice were fed BrdUrd con-
tinuously in their drinking water. We then monitored the
mice by flow cytometry to track the accumulation of T
cells that had undergone cell division and thereby incorpo-
rated BrdUrd into their DNA. The results of this analysis
are shown in Fig. 4 A.
Early loss of CD4 (in Cd4 /  or in Cd4lox/  dLck-hcre3785
mice) led to exaggerated proliferation in peripheral CD4
lineage cells. These cells were also enriched for the display
of markers typical of memory cells (28) or cells expanding
in a T cell void (29, 30) such as low expression of CD62L
or high expression of CD44 (Fig. 4 B and data not shown).
There was also an increase in apoptosis among fresh ex vivo
CD4 lineage T cells from these mice (Fig. 4 C). Together,
these findings are entirely consistent with previously pub-
lished results showing decreased survival and enhanced
turnover when Th cells undergo positive selection without
CD4 (26).
In contrast to the consequences of early loss of CD4, its
later loss in Cd4lox/  dLck-hcre3778 or dLck-hcre3779 mice was
not associated with increased proliferation (Figs. 4 A, 6 B,
and data not shown). Th cells in these mice incorporated
BrdUrd at a rate that was consistently lower than CD4  T
cells in control mice that did not express Cre. Indeed,
CD4  T cells in the Cd4lox/  dLck-hcre3778 or dLck-hcre3779
mice reproducibly showed enhanced proliferation relative
to the CD4 CD8  T cells in the same mice. The
CD4 CD8   population was not enriched for memory
phenotype cells nor was it prone to apoptosis, as detected
by annexin V staining (Fig. 4 B and C). Thus, late loss of
CD4 in these mice did not cause the enhanced turnover
and increased apoptosis found in the CD4 lineage cells of
Cd4 /  or Cd4lox/  dLck-hcre3785 mice. Instead, if anything,
late loss of CD4 caused reduced turnover of the CD4-defi-
cient Th cells, perhaps indicating that they were less capa-
ble of making a homeostatic proliferative response than the
Figure 2. T cell populations in Cd4lox/  dLck-hcre trans-
genic mice. Thymocytes at progressively increasing stages
of maturity (first three columns) and T cells were analyzed
by three-color flow cytometry using directly conjugated
fluorescent anti-CD4, CD8, and TCR-  mAbs. All but
the last row of contour plots (from Cd4 /  mice) show
cells from mice that carried the conditional Cd4 allele bal-
anced by a null Cd4 allele, and that were also transgenic for
the indicated dLck-hcre insertions. The contour plots show
the relative representation of populations defined by CD4
and CD8 expression.1725 Wang et al.
cells that retained CD4 in the same mice. To examine this
last possibility, we performed two types of experiments that
tested the capacity of CD4-deficient T cells to proliferate
under circumstances of induced T cell deficiency. The first
of these experiments involved labeling T cells from the
mutant mice with CFSE and then transferring them into T
cell–deficient recipients by intravenous injection. The
other type of experiment examined the proliferative re-
sponse of CD4  T cells in Cd4lox/  dLck-hcre3778 mice that
had been depleted of their CD4-expressing cells by injec-
tion of cytotoxic anti-CD4 mAb.
To facilitate adoptive transfer experiments between mice
that were not on the same genetic background, we first gen-
erated bone marrow chimeras using cells from dLck-hcre3778
Cd4lox/  mice as donors and irradiated C57BL/6 mice as re-
cipients. T cells developing in these chimeras would be tol-
erized to the C57BL/6 environment and would therefore
not mediate graft-versus-host responses when subsequently
transferred into C57BL/6 RAG-1 /  congenic recipients.
Donor cells from the bone marrow chimeras were labeled
with CFSE before the secondary adoptive transfers, so that
early rounds of proliferation could be monitored. FACS®
data from a representative experiment are shown in Fig. 5 A.
CD4-deficient T cells from Cd4 /  mice decreased in rep-
resentation immediately after transfer (Fig. 5 B), consistent
Figure 3. Immune responses mediated by CD4-deficient T cells. (A)
Cytokine production by T cells from immunized mice after antigen re-
stimulation in vitro. CD8-depleted spleen cells (containing equivalent
numbers of CD4 lineage cells) from immunized mice (100  g KLH given
intraperitoneally in alum 7 d beforehand) were restimulated in vitro with
50  g/ml KLH for 48 h before harvesting supernatants for IL-4 or IFN- -
specific ELISAs. Cd4lox/  dLck-hcre3778 mice were pretreated with cyto-
toxic anti-CD4 mAb (as described in Materials and Methods) to eliminate
CD4-expressing cells (see Fig. 6 A). (B) Antigen-driven clonal expansion of
LACK-reactive T cells in the absence of CD4. H-2db Cd4lox/  dLck-hcre3778
and dLck-hcre3779 mice carrying the WT15 LACK-reactive TCR-  trans-
gene (reference 9) were immunized with Escherichia coli–derived recombi-
nant LACK in the footpads using Freund’s Complete Adjuvant. Popliteal
lymph nodes were removed 7 d after immunization and the LACK-reac-
tive T cells they contained were identified by multi-color flow cytometry
using a LACK/I-Ad fluorescent multimer (reference 25). The percentages
of CD4-expressing and CD4-deficient T helper cells from the immunized
mice that stained with the multimer are shown in C.
Figure 4. Proliferation and phenotype of CD4-deficient T cells. (A)
The in vivo rates of cell division for CD4-expressing and CD4-deficient
T cells were examined by continuous labeling with BrdUrd. Cells that
had undergone DNA synthesis in vivo were identified by multi-color
flow cytometry using an anti-BrdUrd mAb. The graph shows the accu-
mulation of cells that stained brightly (reference 49) with the anti-BrdUrd
antibody in individual mice analyzed at different time points. The data are
representative of those obtained in two independent experiments. (B)
Representation of CD62L-expressing CD4  and CD4  T cells in early
(3785) and late (3778) -acting dLck-hcre transgenic Cd4lox/  mice. (C) Fre-
quency of Annexin V-stained CD4  and CD4  cells in Cd4lox/  dLck-hcre
transgenic and control mice. Three of the Cd4lox/   dLck-hcre3778 mice
were treated with cytotoxic anti-CD4 mAb as shown in Fig. 6.1726 Conditional Inactivation of the Cd4 Gene
with their high apoptotic index and previously published
data (26). At later times, the numbers of these cells increased
substantially (Fig. 5 B) and the CFSE profiles showed that
many of the transferred cells had proliferated extensively
(data not shown). As observed previously (4, 31), two rates
of proliferation were evident in all of the transferred popula-
tions we followed: some cells underwent  7 rounds of divi-
sion by 4–6 d while the majority appeared to require  30 d
to go through only 2–3 rounds.
Like cells that had lost CD4 as an early event, CD4-defi-
cient cells from the late-acting Cre transgenic mice (line
3778) also responded to the T cell–deficient environment
by proliferating (Fig. 5 A and B). Interestingly, these cells
appeared to suffer a substantial competitive disadvantage in
this response when they were cotransferred with CD4  T
cells. Thus, the magnitude of their proliferative response
was considerably increased when CD4-expressing cells
were depleted from the inoculum immediately before
adoptive transfer. In the presence of competitor CD4  T
cells, the transferred CD4-expressing T cells predominated
and there was a progressive decrease in the relative fre-
quency of CD4-deficient cells. Therefore, the data are
consistent with the BrdUrd studies presented in Fig. 4, and
suggest that competition during normal homeostasis may
discriminate between T cells on the basis of TCR/core-
ceptor signaling.
Injection of cytotoxic anti-CD4 mAb into Cd4lox/ 
dLck-hcre3778 mice eliminated CD4-expressing cells (Fig. 6
A) and caused marked proliferation of the remaining CD4-
deficient T helper cells, as monitored by BrdUrd incorpo-
ration (Fig. 6 B). In contrast to the phenotype of CD4-
deficient cells in Cd4lox/  dLck-hcre3785 and Cd4 /  mice, this
proliferation was not associated with increased apoptosis
Figure 5. Proliferation of
CD4-deficient T cells after
adoptive transfer into lym-
phopenic recipients. (A) FACS®
analysis of CFSE-labeled T cells
removed from RAG-1 /  recip-
ients of cells from dLck-hcre3778
transgenic or nontransgenic
Cd4 /  mice. The third column
shows cells from mice that re-
ceived CD4-depleted dLck-hcre3778
Cd4lox/  T cells. Although tri-
color-conjugated anti-CD4 and anti-CD8 antibodies were used together,
CD4- and CD8-expressing cells could still be distinguished from one an-
other by their different levels of fluorescence, as indicated. (B) Changes in
the relative representation of CD4  and CD4  T cells in RAG-1 / 
mice that received the indicated cell populations. The results of this ex-
periment are representative of two others. Changes in the fraction of cells
that had undergone cell division (assessed by CFSE fluorescence) are
shown in C.
Figure 6. Proliferation of CD4-deficient T cells after in vivo depletion
of CD4-expressing cells. (A) dLck-hcre3778 Cd4lox/  mice were injected
four times with 500  g each of cytotoxic anti-CD4 antibody on days 0,
1, 2, and 6, while being fed BrdUrd continuously in their drinking water.
The FACS® plots show the extent of in vivo CD4 depletion after 7 d. (B)
Accumulation of BrdUrd-labeled CD4  and CD4-deficient cells in anti-
CD4–treated and untreated Cd4lox/   dLck-hcre3778 transgenic mice and
nontransgenic controls.1727 Wang et al.
(Fig. 4 C). Together with the results of immunization ex-
periments (Fig. 3) these data show that cells that have lost
CD4 expression late in their development are not obvi-
ously defective in their capacity to proliferate. Their de-
creased incorporation of BrdUrd (Fig. 4 A) and restrained
expansion in RAG-1 /  mice (Fig. 5) can, however, be
explained by competition with CD4-expressing cells, since
the removal of these cells reveals their proliferative poten-
tial in both cases (Figs. 5 and 6).
In a final series of experiments, we examined the ex-
pression of the CD5 molecule on CD4-expressing and
CD4-deficient T cells in Cd4lox/  dLck-hcre3778 and Cd4lox/ 
dLck-hcre3779 mice. CD5 is a negative regulator of TCR
signaling (32, 33) whose level of expression on the T cell
surface changes in response to the antigenic environment
in which the T cell moves (34). For example, CD4 CD8 
thymocytes from MHC-deficient mice show decreased
cell surface display of CD5 relative to thymocytes from
wild-type mice, whereas autoreactive CD4  T cells show
enhanced levels of cell surface CD5 compared with nor-
mal CD4  T cells (34). If the absence of CD4 impairs the
response of T cells to endogenous peptide–MHC ligands,
then this might be expected to correlate with decreased
cell surface expression of CD5 (35, 36). Consistent with
this expectation, the CD4-deficient population of cells
was relatively more enriched for low expression of CD5
compared with CD4-expressing T cells in the same mice
(Fig. 7 A and B). Thus, impaired homeostatic TCR sig-
naling, as shown here with loss of CD4, induces decreased
expression of the CD5 negative regulator, presumably as a
means of augmenting TCR sensitivity and consequently
homeostatic competitiveness.
Discussion
Using conditional CD4 deficiency as a means to interfere
with the function of the TCR, we have shown that im-
paired TCR/coreceptor signaling decreases the competi-
tiveness of Th cells during homeostatic proliferation. Cells
that had lost CD4 because of Cre recombination showed a
competitive disadvantage compared with CD4-expressing
cells when they were transferred into RAG-1 /  recipi-
ents. Eliminating competitor CD4  T cells relieved the
block to proliferation in these adoptive transfer experi-
ments. CD4-deficient T cells proliferated rapidly in re-
sponse to an induced T cell void caused by antibody-medi-
ated depletion of CD4  T cells, and they also could
undergo efficient clonal expansion in response to inten-
tional antigenic stimulation. Thus, T cells lacking CD4 re-
tained the capacity to proliferate, but failed to realize it
fully during homeostatic expansion in the presence of
CD4-expressing cells. Taken together, the results reveal
evidence of competition among T cells for homeostatic
proliferation cues, and suggest that the basis of this compe-
tition is TCR/coreceptor signaling.
The significance of TCR/coreceptor signaling in regu-
lating the survival of peripheral T cells and selection of the
T cell repertoire after thymic development has been some-
what controversial. Although T cells have shown impaired
survival after transfer to MHC-deficient hosts in some set-
tings (37), the magnitude of this effect has been variable or
undetectable in others (2, 4, 38). Using alternative ap-
proaches to restrict expression of MHC molecules solely to
the thymus (1, 5, 39), other groups have reported reduced
survival of CD4  T cells in the periphery, consistent with a
necessary role for TCR signaling for T cell persistence. Di-
rect support for this position has recently come from re-
ports showing that postthymic loss of TCR expression im-
pairs T cell survival (40, 41), in a less dramatic, but related
fashion to the way in which loss of BCR expression inter-
feres with B cell survival (42). Here, we have described di-
minished T cell competitiveness and reduced in vivo pro-
liferation caused by impairing the TCR signal through
absence of CD4. These data are consistent with the emerg-
ing view that TCR–ligand interactions are important for
postthymic T cell survival and indicate that, for CD4  T
cells, the contribution of CD4 coreceptor is required for
survival signaling.
During immune responses, T cells will compete with
one another for access to antigen (43, 44). This competi-
tion appears to place an upper limit on the number of cell
divisions experienced by an antigen-reactive clone. Thus,
when precursor frequencies are high, T cells undergo fewer
cell divisions than when these frequencies are low (43, 44).
Increasing the display of antigen to T cells, by injecting
mice with antigen-pulsed dendritic cells, can increase the
number of cell divisions a clone experiences (44) presum-
ably by alleviating competition for access to antigen. Com-
petition of this sort has the potential to explain selection for
T cells bearing high affinity TCRs as immune responses
mature (45–48), because such TCRs may enhance compet-
itiveness at the surface of antigen presenting dendritic cells
allowing for increased access to proliferative cues. The data
presented in this paper suggest that TCR-dependent com-
petition may also be a normal part of naive T cell homeo-
stasis, again favoring cells that make high affinity engage-
ments with peptide–MHC ligands at the expense of those
making weaker engagements.
Competition between CD4  and CD4  T cells could
be most readily visualized in the adoptive transfer experi-
Figure 7. Decreased surface expression of CD5 on CD4-deficient T
cells in dLck-hcre Cd4lox/  mice. (A) Cell surface CD5 on CD4  and
CD4 CD8  T cells from dLck-hcre3778 Cd4lox/  mice. (B) Mean CD5
fluorescence intensity (MFI) of CD4 , CD4 , and CD8  T cells in
dLck-hcre3778 and dLck-hcre3779 Cd4lox/  mice.1728 Conditional Inactivation of the Cd4 Gene
ments, but we also observed that CD4-deficient T cells in-
corporated BrdUrd at a significantly reduced rate under
steady-state conditions compared with CD4-expressing
cells in the same mice. In principal, at least some of this
steady-state difference could be attributed to enrichment
for memory T cells within the CD4  population in the
context of previous work showing that memory T cells can
have a shorter cell cycle than naive T cells (49). Quantify-
ing the frequencies of memory versus naive cells in the two
populations is unfortunately made difficult by the fact that
actively proliferating naive T cells can adopt a cell surface
phenotype that is typical of memory cells, despite the ab-
sence of antigen encounter (4, 29, 30). Even with this in
mind, however, we found only a two- to threefold enrich-
ment for memory T cells within the CD4  compartment
of  Cd4lox/  dLck-hcre3778 mice (data not shown), which
seems unlikely to account for the observed differences in
BrdUrd incorporation. Using LACK or KLH immuniza-
tion, we have also shown that CD4-deficient T cells are
capable of engaging in vigorous immune responses, even in
the context of competition with CD4  T cells. Thus, the
differences in steady-state proliferation of CD4  and
CD4  T cells in Cd4lox/  dLck-hcre3778 mice and the differ-
ences in expansion of these cells after adoptive transfer
both seem likely to reflect the same type of TCR-depen-
dent competitive effect.
TCR-based competition between naive T cells during
expansion under lymphopenic conditions and during
steady-state homeostasis implies that the naive TCR reper-
toire is under continual selection beyond the thymus. Spe-
cifically, the data suggest that there is a growth advantage
conferred on T cells that bind endogenous peptide–MHC
ligands with high affinity, and that such cells would tend to
dominate over time at the expense of cells whose TCRs
bind endogenous ligands with lower affinity. There are no
direct experiments that address whether such refinement of
the TCR repertoire is in fact beneficial for the organism. It
seems possible, for instance, that the refined repertoire may
be relatively more enriched for T cells that will be useful
during pathogen-specific immune responses, than a reper-
toire that has not yet undergone refinement. Alternatively,
in the absence of significant thymic output, this type of
repertoire refinement could focus the repertoire over a
long period of time in a fashion that might not be benefi-
cial to the organism. Although we have shown here that
impaired homeostatic competitiveness did not detectably
impair the highly focused immune response to the Leishma-
nia major LACK antigen, additional experiments will be re-
quired to test more adequately the fitness of CD4-deficient
T helper cells, or other populations of cells that also have
suboptimal TCR-dependent signaling responses to endog-
enous peptide–MHC ligands.
The mechanism by which TCR signaling would en-
hance competitiveness remains to be addressed. Whereas it
is possible that TCR signaling itself is directly responsible
for regulating the cell cycle of naive T cells, it is also possi-
ble that the TCR signal induces a state in the cell that
makes it more responsive to other proliferative cues, such
as might be provided by cytokines. For instance, IL-7 has
recently been shown to regulate the proliferation and sur-
vival of both naive and memory T cells (2, 50–53), and
there are increased levels of circulating IL-7 under condi-
tions of lymphopenia (54). Similarly, memory CD8  T
cells rely on a balance of IL-15 and IL-2 receptor signals for
normal homeostasis (50). Thus, it is possible that TCR sig-
naling might induce or downregulate sensitivity to a cyto-
kine either at the level of the receptor itself or the signaling
molecules downstream of it. Polyclonal CD4  and CD4 
populations that differ in their homeostatic competitiveness
should be useful tools for examining these possibilities.
Early loss of CD4 in the thymus, as in Cd4 /  mice or
Cd4lox/  dLck-hcre3785 mice, creates Th lineage cells that are
both prone to apoptosis and have a high mitotic index
(26). In contrast, cells that lose CD4 later in the develop-
mental pathway (e.g., as found in Cd4lox/  dLck-hcre3778
mice) are not abnormally apoptotic and, as just mentioned
they also demonstrate a low rate of proliferation. Thus, the
loss of CD4 incurs two very different phenotypes on cells,
dependent on whether it occurs before or primarily after
positive selection in the thymus. The low rate of prolifera-
tion in Cd4lox/   dLck-hcre3778 mice is at least partly ex-
plained by competition as it can be significantly if not
completely eliminated by deletion of CD4-expressing cells
from the mice (Figs. 5 and 6). Importantly, however, pro-
liferation of CD4  cells after in vivo depletion of CD4  T
cells, does not increase the frequency of apoptotic cells
over the time course examined (Fig. 4). This finding sug-
gests that the two phenotypes observed in Cd4 /  mice
(26) can be separable, i.e., proliferation of Th cells that lack
CD4 can occur in the absence of an associated increase in
cell death. The cause of the apoptotic phenotype exhibited
by  Cd4 /  T cells is therefore not necessarily a conse-
quence of the proliferative stress incurred by reduced thy-
mic output of helper lineage cells. Instead, it may well re-
flect a more direct consequence of CD4 deficiency, such as
aberrant or incomplete differentiation of thymocytes when
they lack efficient TCR/coreceptor signaling. Such an in-
terpretation makes clear the benefit of the conditional mu-
tagenesis approach, and the types of mouse strains used
here, because they permit a dissociation of pre- and post-
developmental effects of genes that have multiple roles in a
linear differentiation pathway.
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